Labcorp Holdings Inc. LH

LH Company Overview

Labcorp Holdings Inc. is a global life sciences and healthcare diagnostics company headquartered in Burlington, North Carolina. The company operates primarily through laboratory testing services and drug development support, serving healthcare providers, hospitals, pharmaceutical companies, biotechnology firms, government agencies, and patients. Labcorp is widely recognized as one of the largest clinical laboratory networks in the world and operates across the diagnostics, biopharma, and clinical trial support industries. Its primary revenue drivers include routine and specialty diagnostic testing, central laboratory services for clinical trials, companion diagnostics, and drug development support services.

The company traces its origins to Roche BioMedical and National Health Laboratories, which merged in 1995 to form Laboratory Corporation of America Holdings. Over time, Labcorp expanded through acquisitions and strategic integrations, including the acquisition of Covance in 2015, which significantly expanded its drug development and clinical research capabilities. In 2023, Labcorp completed the spin-off of its clinical development business into Fortrea Holdings Inc., reshaping the company’s strategic focus toward diagnostics and laboratory services. The company’s scale, broad testing menu, payer relationships, and extensive laboratory infrastructure provide competitive advantages in both routine diagnostics and specialized testing markets.